List view / Grid view

Richard Goodwin

 

Richard Goodwin

Principal Scientist, Drug Safety and Metabolism at AstraZeneca

11 October 2017 | By

Principal Scientist, Drug Safety and Metabolism at AstraZeneca

Mass spectrometry imaging in drug discovery

Mass spectrometry imaging allows direct measurement of the molecular composition…

11 September 2017 | By ,

Mass spectrometry imaging allows direct measurement of the molecular composition of a sample. It can be used to image the spatial distribution of exogenous drugs and endogenous metabolites simultaneously over the surface of tissue sections or small biopsy, allowing new insights into both compound efficacy and safety during drug discovery.

Imaging In-Depth Focus 2017

This In-Depth Focus explores current uses and future development in…

11 September 2017 | By

This In-Depth Focus explores current uses and future development in mass spectrometry imaging for bringing new drugs to market...

Drug Target Review – Issue #3 2017

Included in this issue: The importance of industry partnerships; Calcilytics…

6 September 2017 | By

Included in this issue: The importance of industry partnerships; Calcilytics as potential novel therapeutic treatments to halt Alzheimer's disease; Accelerating neuroscience research with flow cytometry...

Send this to a friend